The landscape of targeted immune responses in the HIV-1 vaccine field.
HIV-1 vaccine development is rapidly advancing numerous diverse vaccine candidates based on a variety of hypotheses about what contributes to protective HIV-1 immunity (1–3). It is common to differentiate vaccine candidates as being antibody-based, T-cell-based, or both, which is a useful classifica...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Mary-Ann Liebert
2016
|